Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis

Ann Pharmacother. 2004 Nov;38(11):1969-70. doi: 10.1345/aph.1E274. Epub 2004 Sep 28.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Methotrexate / adverse effects*
  • Middle Aged
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / chemically induced*

Substances

  • Antirheumatic Agents
  • Methotrexate